Viewing Study NCT02407405

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:25 AM
Ignite Modification Date: 2026-03-01 @ 10:10 AM
Study NCT ID: NCT02407405
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-10
First Post: 2015-04-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neurofibromatosis 1 (NF1) View
None Plexiform Neurofibromas (PN) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Objective Response View
None pERK inhibition View
None MEK Inhibition View
None Biopsy View
None Volumetric MRI View